Email This Article

Additional Contamination Identified in Medical Products from New England Compounding Center
As part of the ongoing investigation of the multistate outbreak of fungal meningitis and other infections, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) continue to test medical products from the New England Compounding Center (NECC) in Framingham,
To (required; use comma between emails, max Three):
 
Subject (required):
 
Your email address (required):
 
Message:
The message area is limited to 500 characters and allows for no html, URLs, email addresses or attachments.